TipHub

1,916.5

+26.46 +1.40%

As of 27 Jul 2026 · delayed

NSE Listed

LT-ASM · ASM 1
What does LT-ASM · ASM 1 mean?
BSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-06-03
NSE · Long Term Additional Surveillance Measure (ASM 1)LT-ASM is the joint SEBI/exchange framework for SUSTAINED abnormal price moves (contrast ST-ASM's 5–15-day spikes). Entry is beta-adjusted price variation versus the Nifty (e.g. 3-month high-low above 150% plus the stock's β × index move) along with client-concentration checks. Stages I–IV escalate from a 5% price band through 100% margin to Trade-for-Trade with an additional surveillance deposit. Practical meaning: the exchange still considers the price action abnormal — tighter bands and elevated margins continue even if another measure (like ESM) has lifted. A stock can sit under LT-ASM on both exchanges via either exchange's shortlisting; it is a preventive cost-of-speculation measure, not an adverse finding against the company.Criteria: High 3-month / 12-month high-low price variation, close-to-close price variation, client concentration, number of price-band hits, market-wide position limit and P/E — applied in graded Stages I–IV with escalating margin and price-band curbs.Exchange notice · 2026-07-14

Wockhardt Limited (WOCKPHARMA)

Volume: 2,69,719Avg Vol 1W: 4,39,364.4Avg Vol 1M: 6,02,543.152W Range:1,086.72,422.3
Key Ratios
Checked 2d ago
Market Cap₹30,315 Cr
Current Price₹1,916.5
Previous Close₹1,890.04
High / Low (52w)₹2,422.3 / ₹1,086.7
Volume2,69,719
Avg Vol (1W)4,39,364.4
Avg Vol (1M)6,02,543.1
Stock P/E106.73
Book Value₹304.03
Dividend Yield0%
ROE5.75%
ROA231%
Revenue (TTM)₹3,484 Cr
Revenue Growth7.7%
Profit Margin6.31%
Total Debt₹1,211 Cr
Shares Outstanding16 Cr
Face Value₹5
EPS (TTM)₹17.48
P/B6.14
Debt / Equity0.46
50 DMA₹1,915.86
200 DMA₹1,509.73
Day change+1.40%
SurveillanceLT-ASM · ASM 1
Price Chart
1,916.5 12.91% · 1Y
215311002.3Cr
2025-07-29
2026-07-27

20-day avg volume: 6.0L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 24% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 107.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹739 Cr₹809 Cr₹721 Cr₹743 Cr₹738 Cr₹782 Cr₹888 Cr₹965 Cr
EBITDA₹67 Cr₹64 Cr₹81 Cr₹26 Cr₹36 Cr₹146 Cr₹137 Cr₹217 Cr
Net Profit₹-14 Cr₹-22 Cr₹14 Cr₹-25 Cr₹-90 Cr₹78 Cr₹59 Cr₹166 Cr
EPS
Profit & Loss (Annual)
MetricDec 2024Mar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026
Revenue₹325 Cr₹3,074 Cr₹355 Cr₹413 Cr₹380 Cr₹430 Cr₹3,484 Cr₹516 Cr
EBITDA₹26 Cr₹238 Cr₹80 Cr₹110 Cr₹98 Cr₹88 Cr₹536 Cr₹173 Cr
Net Profit₹-22 Cr₹-47 Cr₹40 Cr₹69 Cr₹54 Cr₹28 Cr₹213 Cr₹167 Cr
EPS-3.0213.1
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹7,844 Cr₹8,179 Cr₹7,774 Cr₹8,243 Cr₹7,683 Cr₹7,649 Cr₹8,135 Cr₹8,615 Cr
Total Liabilities₹4,840 Cr₹5,121 Cr₹4,015 Cr₹4,041 Cr₹4,021 Cr₹3,987 Cr₹3,478 Cr₹3,334 Cr
Equity₹3,005 Cr₹3,057 Cr₹3,759 Cr₹4,202 Cr₹3,662 Cr₹3,662 Cr₹4,657 Cr₹5,281 Cr
Total Debt
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹224 Cr₹666 Cr₹-170 Cr₹510 Cr₹164 Cr₹249 Cr₹-53 Cr₹411 Cr
Investing₹95 Cr₹-156 Cr₹1,470 Cr₹-201 Cr₹-125 Cr₹-137 Cr₹-783 Cr₹-241 Cr
Financing₹-776 Cr₹-680 Cr₹-1,171 Cr₹-71 Cr₹-315 Cr₹334 Cr₹409 Cr₹-54 Cr
Free Cash Flow₹224 Cr₹666 Cr₹-170 Cr₹510 Cr₹164 Cr₹249 Cr₹-53 Cr₹411 Cr
Shareholding
Promoter 49.08% Institutions 16.46% Public 34.46%
Efficiency & Working Capital
ROCE7.4%
Interest Coverage2.5
Dividend Payout
Debtor Days80 d
Inventory Days88 d
Payable Days72 d
Cash Conversion Cycle96 d
Working Capital Days168 d
Shareholding Details

As of 2026-06-30

Promoter49.1%
FII7.2%
DII9.2%
Institutions16.5%
Public34.5%
Promoter Pledge14.7%
No. of Shareholders1,66,518
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodMar 2024Jun 2024Sept 2024Nov 2024Nov 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters51.6%52%52%49.1%49.1%49.1%49.1%49.1%49.1%49.1%49.1%49.1%
FIIs5.5%5.9%6.7%6.6%6.6%6.5%6.8%7.3%7.1%7%7.1%7.2%
DIIs4.8%4.4%5.1%9.9%9.9%9.8%10.6%11%11%10.5%11%9.2%
Public38.1%37.6%36.2%34.4%34.4%34.5%33.5%32.6%32.8%33.4%32.9%34.5%
Promoter Pledge52.9%37.5%33.6%36.1%36.1%17%18.2%15.6%21.3%18%18.8%14.7%
No. of Shareholders1,46,1381,40,3911,38,1421,43,8761,43,8761,42,7101,41,7991,46,9181,37,9461,42,2741,39,0161,66,518
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Themisto Trustee Company Private LimitedShareholding of Promoter and Promoter Group40.2%6.52 Cr
Pasithee Trustee Company Private LimitedShareholding of Promoter and Promoter Group2.7%44,20,000
Ananke Trustee Company Private LimitedShareholding of Promoter and Promoter Group2.4%38,10,693
Tata Mutual Fund - Tata Small Cap FundPublic Shareholding2%33,01,872
Callirhoe Trustee Company Private LimitedShareholding of Promoter and Promoter Group1.9%31,12,079
Rekha JhunjhunwalaPublic Shareholding1.8%28,37,005
Hsbc Mutual Fund - Hsbc Small Cap FundPublic Shareholding1.3%21,19,318
3p India Equity Fund 1Public Shareholding1.2%18,61,895
Callirhoe Trustee Company Private LimitedShareholding of Promoter and Promoter Group0.6%9,36,751
Pasithee Trustee Company Private LimitedShareholding of Promoter and Promoter Group0.4%6,50,000
Habil F KhorakiwalaShareholding of Promoter and Promoter Group0.4%5,95,486
Murtaza Habil KhorakiwalaShareholding of Promoter and Promoter Group0.2%2,94,060
Huzaifa Habil KhorakiwalaShareholding of Promoter and Promoter Group0.2%2,80,800
Ananke Trustee Company Private LimitedShareholding of Promoter and Promoter Group0.2%2,74,530
Themisto Trustee Company Private LimitedShareholding of Promoter and Promoter Group0.1%1,30,000
Nafisa Habil KhorakiwalaShareholding of Promoter and Promoter Group0%5,565
Miqdad H KhorakiwalaShareholding of Promoter and Promoter Group0%2,340
Muayyad H KhorakiwalaShareholding of Promoter and Promoter Group0%1,800
Zahabiya KhorakiwalaShareholding of Promoter and Promoter Group0%0
Dartmour Holdings Private LimitedShareholding of Promoter and Promoter Group0%0
Palanpur Holdings And Investments Private LimitedShareholding of Promoter and Promoter Group0%0
Khorakiwala Holdings And Investments Private LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Themisto Trustee Company Private Limited1.17 Cr18%2026-06-30
Board of Directors
NameDesignationYear
H F KhorakiwalaExecutive Chairman2025
Murtaza H KhorakiwalaManaging Director2025
Huzaifa H KhorakiwalaExecutive Director2025
Vinesh Kumar JairathIndependent Director2025
Zahabiya KhorakiwalaNon-Executive & Non-Independent Director2025
Akhilesh GuptaIndependent Director2025
Amelia FernandesIndependent Director2025
Rashmi MamturaCompany Sec. & Compli. Officer2025
Ahmad JavedIndependent Director2025
Om Prakash BhattAdditional Director2025
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹51258181
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202579000142,8963,701
20254680002,6963,164
2025300058
Insider / Designated-Person Trades

21 recent disclosure(s)

Muayyad KhorakiwalaAcquisition · 1,800
Themisto Trustee Company Private LimitedPledge · 17,40,000
Themisto Trustee Company Private LimitedPledge · 52,20,000
Themisto Trustee Company Private LimitedPledge · 19,00,000
Themisto Trustee Company Private LimitedPledge · 4,00,000
Themisto Trustee Company Private LimitedPledge · 13,50,000
Substantial Acquisitions (SAST)

6 disclosure(s)

Pledge Released15/05/2024 - 26/06/2024 ·
Pledge29/04/2024 ·
Release Of Pledge21/02/2024 ·
Release Of Pledge29/12/2023 ·
Pledge25/10/2023 ·
Release of Shares20/09/2023 ·
Company Information
Incorporated1999
ChairmanH F Khorakiwala
AuditorMSKC & Associates LLP
Investor Email[email protected]
🌐 www.wockhardt.com

📍 D-4 MIDC, Chikalthana, AURANGABAD, Maharashtra, 431006

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search